keyword
https://read.qxmd.com/read/38627686/development-of-a-smartphone-screening-test-for-preclinical-alzheimer-s-disease-and-validation-across-the-dementia-continuum
#21
JOURNAL ARTICLE
Jane Alty, Lynette R Goldberg, Eddy Roccati, Katherine Lawler, Quan Bai, Guan Huang, Aidan D Bindoff, Renjie Li, Xinyi Wang, Rebecca J St George, Kaylee Rudd, Larissa Bartlett, Jessica M Collins, Mimieveshiofuo Aiyede, Nadeeshani Fernando, Anju Bhagwat, Julia Giffard, Katharine Salmon, Scott McDonald, Anna E King, James C Vickers
BACKGROUND: Dementia prevalence is predicted to triple to 152 million globally by 2050. Alzheimer's disease (AD) constitutes 70% of cases. There is an urgent need to identify individuals with preclinical AD, a 10-20-year period of progressive brain pathology without noticeable cognitive symptoms, for targeted risk reduction. Current tests of AD pathology are either too invasive, specialised or expensive for population-level assessments. Cognitive tests are normal in preclinical AD...
April 16, 2024: BMC Neurology
https://read.qxmd.com/read/38627266/bright-light-therapy-versus-physical-exercise-to-prevent-co-occurring-depression-in-adolescents-and-young-adults-with-attention-deficit-hyperactivity-disorder-a-multicentre-three-arm-randomised-controlled-pilot-phase-iia-trial
#22
JOURNAL ARTICLE
Jutta S Mayer, Laura Kohlhas, Jacek Stermann, Juliane Medda, Geva A Brandt, Oliver Grimm, Adam D Pawley, Philip Asherson, Judit Palacio Sanchez, Vanesa Richarte, Douwe Bergsma, Elena D Koch, Adrià Muntaner-Mas, Ulrich W Ebner-Priemer, Meinhard Kieser, Wolfgang Retz, Francisco B Ortega, Michael Colla, Jan K Buitelaar, Jonna Kuntsi, Josep A Ramos-Quiroga, Andreas Reif, Christine M Freitag
Depression is common in attention-deficit/hyperactivity disorder (ADHD), but preventive behavioural interventions are lacking. This randomised controlled, pilot phase-IIa trial aimed to study a physical exercise intervention (EI) and bright light therapy (BLT)-both implemented and monitored in an individual, naturalistic setting via a mobile health (m-health) system-for feasibility of trial design and interventions, and to estimate their effects on depressive symptoms in young people with ADHD. Two hundred seven participants aged 14-45 years were randomised to 10-week add-on intervention of either BLT (10,000 lx; daily 30-min sessions) (n = 70), EI (aerobic and muscle-strengthening activities 3 days/ week) (n = 69), or treatment-as-usual (TAU) (n = 68), of whom 165 (80%) were retained (BLT: n = 54; EI: n = 52; TAU: n = 59)...
April 16, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38626653/extracorporeal-vs-conventional-cpr-for-out-of-hospital-cardiac-arrest-a-systematic-review-and-meta-analysis
#23
JOURNAL ARTICLE
Jing-Yi Wang, Yan Chen, Run Dong, Shan Li, Jin-Min Peng, Xiao-Yun Hu, Wei Jiang, Chun-Yao Wang, Li Weng, Bin Du
BACKGROUND: Out-of-hospital cardiac arrest (OHCA) remains a significant cause of mortality and morbidity worldwide. Extracorporeal cardiopulmonary resuscitation (ECPR) is a potential intervention for OHCA, but its effectiveness compared to conventional cardiopulmonary resuscitation (CCPR) needs further evaluation. METHOD: We systematically searched PubMed, Embase, the Cochrane Library, Web of Science, and ClinicalTrials.gov for relevant studies from January 2010 to March 2023...
April 6, 2024: American Journal of Emergency Medicine
https://read.qxmd.com/read/38625400/genetic-diagnosis-and-detection-rates-using-c9orf72-repeat-expansion-and-a-multi-gene-panel-in-amyotrophic-lateral-sclerosis
#24
JOURNAL ARTICLE
Dalit Barel, Daphna Marom, Penina Ponger, Alina Kurolap, Anat Bar-Shira, Idit Kaplan-Ber, Adi Mory, Beatrice Abramovich, Yuval Yaron, Vivian Drory, Hagit Baris Feldman
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. It is mostly sporadic, with the C9orf72 repeat expansion being the most common genetic cause. While the prevalence of C9orf72-ALS in patients from different populations has been studied, data regarding the yield of C9orf72 compared to an ALS gene panel testing is limited.We aimed to explore the application of C9orf72 versus a gene panel in the general Israeli population. A total of 140 ALS patients attended our Neurogenetics Clinic throughout 2018-2023...
April 16, 2024: Journal of Neurology
https://read.qxmd.com/read/38625399/clinical-trial-evidence-of-quality-of-life-effects-of-disease-modifying-therapies-for-multiple-sclerosis-a-systematic-analysis
#25
REVIEW
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
BACKGROUND: Increasingly, patients, clinicians, and regulators call for more evidence on the impact of innovative medicines on quality of life (QoL). We assessed the effects of disease-modifying therapies (DMTs) on QoL in people with multiple sclerosis (PwMS). METHODS: Randomized trials assessing approved DMTs in PwMS with results for at least one outcome referred to as "quality of life" were searched in PubMed and ClinicalTrials.gov. RESULTS: We identified 38 trials published between 1999 and 2023 with a median of 531 participants (interquartile range (IQR) 202 to 941; total 23,225)...
April 16, 2024: Journal of Neurology
https://read.qxmd.com/read/38622638/a-methodological-review-of-randomised-n-of-1-trials
#26
REVIEW
Olivia Hawksworth, Robin Chatters, Steven Julious, Andrew Cook, Katie Biggs, Kiera Solaiman, Michael C H Quah, Sxe Chang Cheong
BACKGROUND: n-of-1 trials are a type of crossover trial designed to optimise the evaluation of health technologies in individual patients. This trial design may be considered for the evaluation of health technologies in rare conditions where fewer patients are available to take part in research. This review describes the characteristics of randomised n-of-1 trials conducted over the span of 12 years, including how the n-of-1 design has been employed to study both rare and non-rare conditions...
April 16, 2024: Trials
https://read.qxmd.com/read/38622273/safety-and-efficacy-of-the-novel-alpha-stent-for-the-treatment-of-intracranial-wide-necked-aneurysm
#27
JOURNAL ARTICLE
Junhyung Kim, Jung-Jae Kim, Seung Won Kim, Jinyoung Choi, Hanki Kim, Jinwoo Kim, Joonho Chung
The Alpha stent is an intracranial closed-cell stent with a unique mesh design to enhance wall apposition. It recently underwent structural modifications to facilitate easier stent deployment. This study aimed to evaluate the safety and efficacy of stent-assisted coil embolization for unruptured intracranial aneurysms using the Alpha stent. Between January 2021 and November 2021, 35 adult patients with 35 unruptured intracranial aneurysms in the distal internal carotid artery were prospectively enrolled. For efficacy outcomes, magnetic resonance angiography at the 6-month follow-up was evaluated using the Raymond-Roy occlusion classification (RROC)...
April 16, 2024: Scientific Reports
https://read.qxmd.com/read/38622054/pharmacotherapeutic-strategies-for-friedreich-ataxia-a-review-of-the-available-data
#28
REVIEW
Katherine Gunther, David R Lynch
INTRODUCTION: Friedreich ataxia (FRDA) is a rare autosomal recessive disease, marked by loss of coordination as well as impaired neurological, endocrine, orthopedic, and cardiac function. There are many symptomatic medications for FRDA, and many clinical trials have been performed, but only one FDA-approved medication exists. AREAS COVERED: The relative absence of the frataxin protein (FXN) in FRDA causes mitochondrial dysfunction, resulting in clinical manifestations...
April 15, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38621994/-identification-of-1-3-8-triazaspiro-4-5-decane-2-4-dione-derivatives-as-a-novel-delta-opioid-receptor-selective-agonist-chemotype
#29
JOURNAL ARTICLE
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Delta opioid receptors hold potential as a target for neurological and psychiatric disorders, yet no delta opioid receptor agonist has proven efficacious in critical phase II clinical trials. The exact reasons for the failure to produce quality drug candidates for the delta opioid receptor is nuclear. However, it is known that certain delta opioid receptor agonists can induce seizures and exhibit tachyphylaxis. Several studies have suggested that those adverse effects are more prevalent in delta agonists that share the SNC80/BW373U86 chemotype...
April 15, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38621449/an-improved-method-for-generating-human-spinal-cord-neural-stem-cells
#30
JOURNAL ARTICLE
Y Li, H Kumamaru, T Vokes, A Tran, C Shevinsky, L Graham, K Archuleta, K Limon, P Lu, A Blesch, M H Tuszynski, J H Brock
Neural stem cells have exhibited efficacy in pre-clinical models of spinal cord injury (SCI) and are on a translational path to human testing. We recently reported that neural stem cells must be driven to a spinal cord fate to optimize host axonal regeneration into sites of implantation in the injured spinal cord, where they subsequently form neural relays across the lesion that support significant functional improvement. We also reported methods of deriving and culturing human spinal cord neural stem cells derived from embryonic stem cells that can be sustained over serial high passage numbers in vitro, providing a potentially optimized cell source for human clinical trials...
April 13, 2024: Experimental Neurology
https://read.qxmd.com/read/38619744/imaging-findings-and-toxicological-mechanisms-of-nervous-system-injury-caused-by-diquat
#31
JOURNAL ARTICLE
Yanguang Ren, Feng Guo, Lin Wang
Diquat (DQ) is a nonselective bipyridine herbicide with a structure resembling paraquat (PQ). In recent years, the utilization of DQ as a substitute for PQ has grown, leading to an increase in DQ poisoning cases. While the toxicity mechanism of DQ remains unclear, it is primarily attributed to the intracellular generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) through the process of reduction oxidation. This results in oxidative stress, leading to a cascade of clinical symptoms...
April 15, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38619597/which-parameters-influence-cognitive-psychiatric-and-long-term-seizure-outcome-in-mesial-temporal-lobe-epilepsy-after-selective-amygdalohippocampectomy
#32
JOURNAL ARTICLE
Judith Jud, Harald Stefanits, Ellen Gelpi, Valérie Quinot, Susanne Aull-Watschinger, Thomas Czech, Christian Dorfer, Karl Rössler, Christoph Baumgartner, Gregor Kasprian, Clara Watschinger, Doris Moser, Jonas Brugger, Ekaterina Pataraia
BACKGROUND: We aimed to analyze potentially prognostic factors which could have influence on postoperative seizure, neuropsychological and psychiatric outcome in a cohort of patients with mesial temporal lobe epilepsy (MTLE) due to hippocampal sclerosis (HS) after selective amygdalohippocampectomy (SAHE) via transsylvian approach. METHODS: Clinical variables of 171 patients with drug-resistant MTLE with HS (88 females) who underwent SAHE between 1994 and 2019 were evaluated using univariable and multivariable logistic regression models, to investigate which of the explanatory parameters can best predict the outcome...
April 15, 2024: Journal of Neurology
https://read.qxmd.com/read/38618595/a-simplified-protocol-for-tracheostomy-decannulation-in-patients-weaned-off-prolonged-mechanical-ventilation
#33
JOURNAL ARTICLE
K Devaraja, C S Majitha, Kailesh Pujary, Dipak Ranjan Nayak, Shwethapriya Rao
Introduction  The criteria for the removal of the tracheostomy tube (decannulation) vary from center to center. Some perform an endoscopic evaluation under anesthesia or computed tomography, which adds to the cost and discomfort. We use a simple two-part protocol to determine the eligibility and carry out the decannulation: part I consists of airway and swallowing assessment through an office-based flexible laryngotracheoscopy, and part II involves a tracheostomy capping trial. Objective  The primary objective was to determine the safety and efficacy of the simplified decannulation protocol followed at our center among the patients who were weaned off the mechanical ventilator and exhibited good swallowing function clinically...
April 2024: International Archives of Otorhinolaryngology
https://read.qxmd.com/read/38617553/sensory-processing-difficulties-and-occupational-therapy-outcomes-for-functional-neurological-disorder-a-retrospective-cohort-study
#34
JOURNAL ARTICLE
Kathryn E McCombs, Julie MacLean, Sara A Finkelstein, Susan Goedeken, David L Perez, Jessica Ranford
BACKGROUND AND OBJECTIVES: Occupational therapy (OT) consensus recommendations and articles outlining a sensory-based OT intervention for functional neurological disorder (FND) have been published. However, limited research has been conducted to examine the efficacy of OT interventions for FND. We performed a retrospective cohort study aimed at independently replicating preliminarily characterized sensory processing difficulties in patients with FND and reporting on clinical outcomes of a sensory-based OT treatment in this population...
June 2024: Neurology. Clinical Practice
https://read.qxmd.com/read/38617400/comparison-of-phototherapy-effect-with-and-without-phenobarbital-on-the-newborns-with-hyperbilirubinemia
#35
JOURNAL ARTICLE
Ahmad Shah Farhat, Reza Saeidi, Ashraf Mohammadzadeh, Saeid Reza Lotfi, Mahmoud Hajipour
OBJECTIVES: Jaundice occurs in 60% of full-term and 80% of pre-term newborns. This study compared the effect of phototherapy with and without phenobarbital on icteric newborns. MATERIALS & METHODS: This study is a randomized clinical trial conducted from July until March 2018 at Imam Reza Hospital, Mashhad University of Medical Science, Iran. Full-term and near-term neonates with more than 2000 grams who were hospitalized in the mentioned period for jaundice were entered into the study...
2024: Iranian Journal of Child Neurology
https://read.qxmd.com/read/38617394/efficacy-of-probiotics-in-prevention-of-migraine-attacks-in-children-a-randomized-clinical-trial-study
#36
JOURNAL ARTICLE
Hassan Bazmamoum, Bentolhoda Keshtkarsohi, Younes Mohammadi, Afshin Fayyazi
OBJECTIVES: Migraine is a chronic and joint disease in children. The results of previous studies on the effectiveness of probiotics in preventing migraine attacks in children have been controversial. This study aims to investigate the effect of probiotics on migraine prophylaxis in children. MATERIALS & METHODS: In this clinical trial study, 41 children aged 5 to 15 with migraine enrolled the study in two control and intervention groups. Children in the intervention group (18 children) received propranolol at a dose of 1 mg per kilogram of body weight daily in two divided doses along with a 250 mg Yomogi capsule daily for three months, and children in the control group (23 children), received propranolol along with placebo for three months...
2024: Iranian Journal of Child Neurology
https://read.qxmd.com/read/38614137/prospective-randomized-pilot-trial-comparing-prophylactic-vs-therapeutic-cerebrospinal-fluid-drainage-during-complex-endovascular-thoracoabdominal-aortic-aneurysm-repair
#37
JOURNAL ARTICLE
Juliet Blakeslee-Carter, Zdenek Novak, Jan O Jansen, Andres Schanzer, Matthew J Eagleton, Mark A Farber, Warren Gasper, W Anthony Lee, Gustavo S Oderich, Carlos H Timaran, Darren B Schneider, Matthew P Sweet, Adam W Beck
BACKGROUND: Endovascular techniques have transformed the management of thoracoabdominal aortic aneurysms (TAAAs). However, spinal cord ischemia (SCI) remains a prevalent and devastating complication. Prophylactic drainage of cerebrospinal fluid (CSF) is among the proposed strategies for prevention of SCI. Although prophylactic CSF drainage is widely used and conceptually attractive, prophylactic CSF drains have not been demonstrated to definitively prevent the occurrence nor mitigate the severity of SCI in endovascular TAAA repair...
April 6, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38613686/the-boon-and-bane-of-nitrous-oxide
#38
REVIEW
Golo Kronenberg, Georgios Schoretsanitis, Erich Seifritz, Sebastian Olbrich
Nitrous oxide (N2O) has been known since the end of the eighteenth century. Today, N2O plays a huge role as a greenhouse gas and an ozone-depleting stratospheric molecule. The main sources of anthropogenic N2O emissions are agriculture, fuel combustion, wastewater treatment, and various industrial processes. By contrast, the contribution of medical N2O to the greenhouse effect appears to be small. The recreational and medical uses of N2O gradually diverged over time. N2O has analgesic and anesthetic effects, making it widely used in modern dentistry and surgery...
April 13, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38613459/quantitative-foot-muscle-magnetic-resonance-imaging-reliably-measures-disease-progression-in-children-and-adolescents-with-charcot-marie-tooth-disease-type-1a
#39
JOURNAL ARTICLE
Carolynne M Doherty, Paige Howard, Luke F O'Donnell, Riccardo Zuccarino, Stephen Wastling, Evelin Milev, Tina Banks, Sachit Shah, Nick Zafeiropoulos, Katherine J Stephens, Anna Sarkozy, Tiffany Grider, Shawna M E Feely, Adnan Manzur, Rosemary R Shy, Mariola Skorupinska, Menelaos Pipis, Emma Nicolaisen, Amy McDowell, Nuran Dilek, Alexander M Rossor, Matilde Laura, Christopher Clark, Francesco Muntoni, Daniel Thedens, John Thornton, Jasper M Morrow, Michael E Shy, Mary M Reilly
Quantitative muscle fat fraction (FF) responsiveness is lower in younger Charcot-Marie-Tooth disease type 1A (CMT1A) patients with lower baseline calf-level FF. We investigated the practicality, validity, and responsiveness of foot-level FF in this cohort involving 22 CMT1A patients and 14 controls. The mean baseline foot-level FF was 25.9 ± 20.3% in CMT1A patients, and the 365-day FF (n = 15) increased by 2.0 ± 2.4% (p < 0.001 vs controls)...
April 13, 2024: Annals of Neurology
https://read.qxmd.com/read/38612615/possible-role-of-cannabis-in-the-management-of-neuroinflammation-in-patients-with-post-covid-condition
#40
REVIEW
Noemi Cárdenas-Rodríguez, Iván Ignacio-Mejía, Jose Correa-Basurto, Humberto Carrasco-Vargas, Marco Antonio Vargas-Hernández, Exal Manuel Albores-Méndez, Rodolfo David Mayen-Quinto, Reynita De La Paz-Valente, Cindy Bandala
The post-COVID condition (PCC) is a pathology stemming from COVID-19, and studying its pathophysiology, diagnosis, and treatment is crucial. Neuroinflammation causes the most common manifestations of this disease including headaches, fatigue, insomnia, depression, anxiety, among others. Currently, there are no specific management proposals; however, given that the inflammatory component involves cytokines and free radicals, these conditions must be treated to reduce the current symptoms and provide neuroprotection to reduce the risk of a long-term neurodegenerative disease...
March 29, 2024: International Journal of Molecular Sciences
keyword
keyword
163025
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.